Accsys Technologies (LSE:AXS) sold less Accoya wood in the five months to August 2026 than a year earlier, yet it told shareholders its full-year Earnings remained on course. How is the acetylated wood producer trying to protect profitability while volumes dip, and how does that sit against a high prior-year base?
What Accsys makes
Accsys Technologies produces modified wood using an acetylation process that the company says improves durability and dimensional stability. Its main products are Accoya, used in windows, doors, cladding and decking, and Tricoya panels. Production is centred at Arnhem in the Netherlands, with a joint venture plant in Kingsport in the United States and a colour treatment operation at Barry in Wales. Its shares are traded on AIM in London and on Euronext Amsterdam, and its accounts are reported in euros.
The September trading update
On 21 September 2026, Accsys reported trading for the five months to 31 August 2026. Group Revenue fell 6% to €56.9 million from €60.4 million, while group sales volumes dropped 11% to 22,186 cubic metres. Volumes at the joint venture rose 3% to 6,767 cubic metres. The company said there had been "significant distributor destocking across all our regions during the period, with North America being most affected", linking this to high distributor inventories built up before US production started and to the effects of conflict in the Middle East.
In response, the company said it had implemented "price increases and proactive cost control to protect profitability". It expects full-year underlying EBITDA, excluding the joint venture, to be broadly in line with market expectations, and said it believes destocking has ended, with inventories stabilising. For the second half it expects sales growth from new distributor programmes, collaboration with manufacturers and regional expansion.
A high base year
The update follows a much better year to 31 March 2026. In preliminary results published on 16 June, Accsys reported revenue up 12% to €153 million and sales volumes up 21% to 77,237 cubic metres. Adjusted EBITDA nearly doubled to €21.2 million, giving a Margin of 11.6% against a 12% target for FY27, and gross margin edged up to 30.9%. The statutory loss before tax narrowed to €0.6 million from €20.8 million. Net Debt eased to €41.4 million, with Leverage improving to 1.96 times from 2.52 times, and free Cash Flow was €10.2 million. During the year it completed a €2.6 million acetyls expansion at Arnhem, added ten distributors and recorded 51% growth in Accoya Color sales. The North American joint venture swung to EBITDA profitability of €0.1 million from a €10.1 million loss.
Chief executive Jelena Arsic van Os said the results reflected "disciplined execution of our FOCUS strategy in a challenging macroeconomic environment". At the Annual General Meeting on 25 September 2026, all 15 resolutions were passed, including the appointment of Deloitte as auditor in place of PwC.
Risks and uncertainties
Price increases can protect margins, but they may also slow Demand if customers resist, especially in a weak construction market. The company's view that destocking is over has yet to be confirmed by later volumes. North America remains exposed to tariffs and to the ramp-up of the Kingsport joint venture, while energy and chemical costs linked to Middle East tensions could squeeze margins. Leverage, though lower, still constrains the balance sheet, and euro-denominated results are subject to currency effects for sterling investors.
Conclusion
Accsys is relying on higher prices and cost control to keep earnings on track while distributor destocking reduces volumes. Its first five months show lower revenue, but the company maintains its underlying EBITDA expectations and points to second-half growth initiatives. Whether volumes recover as inventories normalise will determine how far pricing alone needs to carry profitability.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...